Triethylamine → t-Butyl (2-(5-bromo-1-((5-chlorothiazol-2-yl)carbamoyl)spiro[indoline-3,3'-pyrrolidin]-1'-yl)-2-oxoethyl)carbamate
反応式
[Br:1][C:2]1[CH:3]=[C:4]2[C:10]3([CH2:14][CH2:13][NH:12][CH2:11]3)[CH2:9][N:8]([C:15]([NH:17][C:18]3[S:19][C:20]([Cl:23])=[CH:21][N:22]=3)=[O:16])[C:5]2=[CH:6][CH:7]=1.C(N(CC)CC)C.[C:31]([NH:38][CH2:39][C:40](O)=[O:41])([O:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32].Cl.C(N=C=NCCCN(C)C)C>C(Cl)Cl.O>[Br:1][C:2]1[CH:3]=[C:4]2[C:10]3([CH2:14][CH2:13][N:12]([C:40](=[O:41])[CH2:39][NH:38][C:31](=[O:32])[O:33][C:34]([CH3:35])([CH3:36])[CH3:37])[CH2:11]3)[CH2:9][N:8]([C:15](=[O:16])[NH:17][C:18]3[S:19][C:20]([Cl:23])=[CH:21][N:22]=3)[C:5]2=[CH:6][CH:7]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
The 5-bromo-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide (40 mg, 0.097 mmol) obtained in Example 2 was dissolved in methylene chloride (1.0 mL). Thereafter, triethylamine (27.0 μL, 0.194 mmol), N-Boc glycine (20 mg, 0.116 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (22 mg, 0.116 mmol) were added to the above obtained solution at room temperature, and the obtained mixture was then stirred for 12 hours. Thereafter, the reaction solution was diluted with water, and was then extracted with chloroform. The resultant was dried over anhydrous sodium sulfate and was then concentrated in vacuo. The obtained residue was purified by silica gel column chromatography (chloroform:methanol=10:1) to obtain the captioned compound (22.0 mg, 40%) in the form of a white solid.
後処理
- extractionwas then extracted with chloroform
- dry with materialThe resultant was dried over anhydrous sodium sulfate
- concentrationwas then concentrated in vacuo
- customThe obtained residue was purified by silica gel column chromatography (chloroform:methanol=10:1)
出典と根拠
- ORDレコード
- ord-a8af7786c06e47579e5307ffdf71bb70
- 出典データセット
- uspto-grants-2014_12
- 特許番号
- US08921576B2
反応ノート
読み込み中…